ArchivesMagazine - 29 Jun 2017$390bn wiped off global drug sales forecasts Leading data group downgrades its long term pricing outlook for first time in a decade 29 June 2017|Feature|by Lisa-Marie Janes Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Tax Systems excited by new strategic plan Further setback for The People’s Operator > Issue: 29 Jun 2017 - Page 11 | Contents Next: Further setback for The People’s Operator Previous: Tax Systems excited by new strategic plan Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Lisa-Marie Janes Issue Contents Editor's View Taken over yet remaining on the stock market Feature 98.6% vote in favour of Standard Life/Aberdeen merger London’s shrinking bank industry 150M Hurricane blows Crystal Amber down Which FTSE 350 Shares have Lost Shareholders Money Which FTSE 350 Shares Rewarded Shareholders $390bn wiped off global drug sales forecasts Petropavlovsk co-founder kicked off the board after 23 years’ service Can you profit from a fund with a social conscience? Family fortunes What’s going on with housebuilder Berkeley? Tax Systems excited by new strategic plan Further setback for The People’s Operator Europe setback wipes shine off Warpaint Fortify your defences with Games Workshop Blur is on the verge of collapse Great Ideas Get in quick with this small cap investor Hitch a lift with Eddie Stobart Ultra Electronics has all to play for UK weakness puts brakes on Northgate Investment Trusts Funds to help portfolios blossom News How to get exposure to the booming Eurozone Why Domino’s shares are down 10% in a week Energy u-turn Iomart shock as it reveals major acquisition talks Disappointment in store from Debenhams Film finance play comes to AIM Personal Finance Why do platforms list different versions of the same fund? Queen’s Speech fails to address savings issues Under The Bonnet Franchise firm has tasty profit and dividend appeal Week Ahead Focus on volume and price for Persimmon Can SQS turn growth taps on again? Check in on Booker
